Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

OBJECTIVE: An interim analysis of an all-patient postmarketing surveillance programme in Japan to investigate the safety of tocilizumab for the treatment of rheumatoid arthritis (RA) in the real world. METHODS: This analysis included 3881 patients. Patients received 8 mg/kg of tocilizumab every 4 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Takao, Harigai, Masayoshi, Inokuma, Shigeko, Ishiguro, Naoki, Ryu, Junnosuke, Takeuchi, Tsutomu, Takei, Syuji, Tanaka, Yoshiya, Ito, Kyoko, Yamanaka, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212697/
https://www.ncbi.nlm.nih.gov/pubmed/21852254
http://dx.doi.org/10.1136/ard.2011.151092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212697/
https://www.ncbi.nlm.nih.gov/pubmed/21852254
http://dx.doi.org/10.1136/ard.2011.151092

Ejemplares similares